| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Act Up, the heart of French AIDS activism
|
Marche, Guillaume
|
|
|
20 |
7 |
p. 790-791
|
article
|
| 2 |
Acute respiratory distress syndrome during a pandemic—an obvious diagnosis?
|
Reisinger, Alexander C
|
|
|
20 |
7 |
p. 873
|
article
|
| 3 |
A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation
|
|
|
|
20 |
7 |
p. 769-770
|
article
|
| 4 |
Anita Zaidi
|
Kirby, Tony
|
|
|
20 |
7 |
p. 789
|
article
|
| 5 |
Authors' reply
|
Baud, David
|
|
|
20 |
7 |
p. 775-776
|
article
|
| 6 |
Balanced immunity is key for a successful dengue vaccine
|
Reyes-Sandoval, Arturo
|
|
|
20 |
7 |
p. 761-762
|
article
|
| 7 |
Cabotegravir, a new option for PrEP
|
Kirby, Tony
|
|
|
20 |
7 |
p. 781
|
article
|
| 8 |
Changes in M types of Streptococcus pyogenes in Chinese children with scarlet fever
|
Yu, Dingle
|
|
|
20 |
7 |
p. 780
|
article
|
| 9 |
Congenital syphilis, the great imitator—case report and review
|
Keuning, Maya W
|
|
|
20 |
7 |
p. e173-e179
|
article
|
| 10 |
Connecting clusters of COVID-19: an epidemiological and serological investigation
|
Yong, Sarah Ee Fang
|
|
|
20 |
7 |
p. 809-815
|
article
|
| 11 |
Correction to Lancet Infect Dis 2019; published online April 20. https://doi.org/10.1016/S1473-3099(20)30160-2
|
|
|
|
20 |
7 |
p. e148
|
article
|
| 12 |
Correction to Lancet Infect Dis 2019; published online April 20. https://doi.org/10.1016/S1473-3099(20)30160-2
|
|
|
|
20 |
7 |
p. e148
|
article
|
| 13 |
Correction to Lancet Infect Dis 2020; published online March 27. https://doi.org/10.1016/S1473-3099(20)30200-0
|
|
|
|
20 |
7 |
p. e148
|
article
|
| 14 |
Correction to Lancet Infect Dis 2020; published online March 30. https://doi.org/10.1016/S1473-3099(20)30150-X
|
|
|
|
20 |
7 |
p. e148
|
article
|
| 15 |
Correction to Lancet Infectious Diseases 2020; published online April 27. https://doi.org/10.1016/S1473-3099(20)30287-5
|
|
|
|
20 |
7 |
p. e148
|
article
|
| 16 |
Correction to Lancet Infectious Diseases 2020; published online April 29. https://doi.org/10.1016/ S1473-3099(20)30064-5
|
|
|
|
20 |
7 |
p. e148
|
article
|
| 17 |
COVID-19 and medical education
|
Ahmed, Hanad
|
|
|
20 |
7 |
p. 777-778
|
article
|
| 18 |
COVID-19 in Iran: round 2
|
Venkatesan, Priya
|
|
|
20 |
7 |
p. 784
|
article
|
| 19 |
COVID-19: Playing away the pandemic
|
Balakrishnan, Vijay Shankar
|
|
|
20 |
7 |
p. 792
|
article
|
| 20 |
De-implementation strategy to reduce inappropriate use of intravenous and urinary catheters (RICAT): a multicentre, prospective, interrupted time-series and before and after study
|
Laan, Bart J
|
|
|
20 |
7 |
p. 864-872
|
article
|
| 21 |
Estimating case fatality rates of COVID-19
|
Spychalski, Piotr
|
|
|
20 |
7 |
p. 774-775
|
article
|
| 22 |
Estimating case fatality rates of COVID-19
|
Lipsitch, Marc
|
|
|
20 |
7 |
p. 775
|
article
|
| 23 |
Estimating case fatality rates of COVID-19
|
Kim, David Dongkyung
|
|
|
20 |
7 |
p. 773-774
|
article
|
| 24 |
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study
|
Zhang, Juanjuan
|
|
|
20 |
7 |
p. 793-802
|
article
|
| 25 |
From China: hope and lessons for COVID-19 control
|
Azman, Andrew S
|
|
|
20 |
7 |
p. 756-757
|
article
|
| 26 |
Global outbreak research: harmony not hegemony
|
|
|
|
20 |
7 |
p. 770-772
|
article
|
| 27 |
Global shortage of personal protective equipment
|
Burki, Talha
|
|
|
20 |
7 |
p. 785-786
|
article
|
| 28 |
High COVID-19 testing rate in Portugal
|
Triunfol, Marcia
|
|
|
20 |
7 |
p. 783
|
article
|
| 29 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
20 |
7 |
p. 786
|
article
|
| 30 |
Jacques Acar
|
Balakrishnan, Vijay Shankar
|
|
|
20 |
7 |
p. 788
|
article
|
| 31 |
Modelling COVID-19 transmission: from data to intervention
|
Jia, Zhongwei
|
|
|
20 |
7 |
p. 757-758
|
article
|
| 32 |
New WHO guidelines on the management of pregnancy and breastfeeding in the context of Ebola
|
Thorson, Anna E
|
|
|
20 |
7 |
p. 766-767
|
article
|
| 33 |
Next-generation rotavirus vaccines: important progress but work still to be done
|
Bines, Julie E
|
|
|
20 |
7 |
p. 762-764
|
article
|
| 34 |
Political casualties of the COVID-19 pandemic
|
The Lancet Infectious Diseases,
|
|
|
20 |
7 |
p. 755
|
article
|
| 35 |
Pregnancy and breastfeeding in the context of Ebola: a systematic review
|
Foeller, Megan E
|
|
|
20 |
7 |
p. e149-e158
|
article
|
| 36 |
Real estimates of mortality following COVID-19 infection
|
Baud, David
|
|
|
20 |
7 |
p. 773
|
article
|
| 37 |
Refractory laryngeal papillomatosis requiring total laryngectomy
|
Nishida, Hayato
|
|
|
20 |
7 |
p. 874
|
article
|
| 38 |
Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984–2018: an evaluation of Food and Drug Administration flexibilities
|
Darrow, Jonathan J
|
|
|
20 |
7 |
p. e159-e164
|
article
|
| 39 |
Research brief
|
Mohammadi, Dara
|
|
|
20 |
7 |
p. 787
|
article
|
| 40 |
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
|
Folegatti, Pedro M
|
|
|
20 |
7 |
p. 816-826
|
article
|
| 41 |
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial
|
Koch, Till
|
|
|
20 |
7 |
p. 827-838
|
article
|
| 42 |
Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial
|
Groome, Michelle J
|
|
|
20 |
7 |
p. 851-863
|
article
|
| 43 |
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
|
Kallas, Esper G
|
|
|
20 |
7 |
p. 839-850
|
article
|
| 44 |
Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate schistosomiasis
|
Amoah, Abena S
|
|
|
20 |
7 |
p. e165-e172
|
article
|
| 45 |
Stigma during the COVID-19 pandemic
|
Bagcchi, Sanjeet
|
|
|
20 |
7 |
p. 782
|
article
|
| 46 |
The important role of serology for COVID-19 control
|
Winter, Amy K
|
|
|
20 |
7 |
p. 758-759
|
article
|
| 47 |
The INHALE trial: multiple reasons for a negative result
|
Rouby, Jean-Jacques
|
|
|
20 |
7 |
p. 778-779
|
article
|
| 48 |
The INHALE trial: multiple reasons for a negative result – Authors' reply
|
Niederman, Michael S
|
|
|
20 |
7 |
p. 779-780
|
article
|
| 49 |
The many estimates of the COVID-19 case fatality rate
|
Rajgor, Dimple D
|
|
|
20 |
7 |
p. 776-777
|
article
|
| 50 |
The UK hibernated pandemic influenza research portfolio: triggered for COVID-19
|
Simpson, Colin R
|
|
|
20 |
7 |
p. 767-769
|
article
|
| 51 |
Transforming use of two catheters: from accessory to hazard
|
Meddings, Jennifer
|
|
|
20 |
7 |
p. 764-766
|
article
|
| 52 |
Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?
|
Modjarrad, Kayvon
|
|
|
20 |
7 |
p. 760-761
|
article
|
| 53 |
Using observational data to quantify bias of traveller-derived COVID-19 prevalence estimates in Wuhan, China
|
Niehus, Rene
|
|
|
20 |
7 |
p. 803-808
|
article
|
Journal description